Use of rifampicin and ciprofloxacin combination therapy after surgical debridement in the treatment of early manifestation prosthetic joint infections
Open Access
- 1 October 2005
- journal article
- Published by Elsevier BV in Clinical Microbiology & Infection
- Vol. 11 (10), 843-845
- https://doi.org/10.1111/j.1469-0691.2005.01230.x
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Treatment of Gram-positive bone and joint infection: authors' responseJournal of Antimicrobial Chemotherapy, 2004
- The Economic Costs of Surgical Site InfectionSurgical Infections, 2002
- New Developments in Diagnosis and Treatment of Infection in Orthopedic ImplantsClinical Infectious Diseases, 2001
- Prosthetic Joint Infection: When Can Prosthesis Salvage Be Considered?Clinical Infectious Diseases, 1999
- Role of Rifampin for Treatment of Orthopedic Implant–Related Staphylococcal Infections A Randomized Controlled TrialJAMA, 1998
- Infection after total hip arthroplasty. Past, present, and future.The Journal of Bone & Joint Surgery, 1995
- Total Hip ReplacementJAMA, 1995
- In vivo verification of in vitro model of antibiotic treatment of device-related infectionAntimicrobial Agents and Chemotherapy, 1995
- Antimicrobial Treatment of Orthopedic Implant-related Infections with Rifampin CombinationsClinical Infectious Diseases, 1992
- Correlation between In Vivo and In Vitro Efficacy of Antimicrobial Agents against Foreign Body InfectionsThe Journal of Infectious Diseases, 1990